Melanie (Host): Welcome to UF Health Med EdCast with UF Health Shan's Hospital.
I'm Melanie Cole, and today we're talking about testosterone and fertility.
Joining me is Dr.
Kevin Campbell.
He's an assistant clinical professor and an associate Medical Director
in the Department of Urology at the University of Florida College of Medicine.
Dr.
Campbell, it's such a pleasure to have you join us today.
Let's just start with kind of how common in the prevalence is testosterone
deficiency and disorders in men?
Kevin Campbell, MD: Absolutely.
And Melanie, thanks for having me.
It's a pleasure to be here today.
So testosterone and, the implications of having high and low testosterone,
are really, really, uh, at the forefront of, what I practice on
a day-to-day in clinical medicine.
And it's a topic that's, near to my clinical interests and heart.
So if we're looking at.
The number of people who have testosterone deficiency or, low testosterone,
depending on what clinical picture you look at, you're gonna be seeing somewhere
from like 5% all the way up to 20%.
So it's not without, a big presence in the general community.
And you likely know somebody who either has low testosterone or
testosterone deficiency or is being treated for testosterone
deficiency and may not even know it.
Melanie (Host): Well, since it's so common, speak a little bit about what
would send a man to a physician, whether it's his primary care or urologist.
Tell us some of the signs and symptoms that they might notice
or that a partner might notice.
I.
Kevin Campbell, MD: Absolutely.
there's really two main drivers of men to the physician, especially
for younger, healthier men usually, and that's fertility or sterility.
Men are either trying to, either get a, a vasectomy or, or worried about
their reproductive healthcare or something's going wrong and they're
worried about their testosterone.
And a lot of the times the signs and symptoms may be difficulty with pregnancy.
It may be increased fatigue, it may be low sex drive.
Low muscle mass, decreased, ability to achieve an erection.
Now they're starting to have all this adipose or fat tissue around
their abdomen And also, uh, sometimes orgasmic or other sexual disorders.
And the thing we worry about with these is we try to screen them early
because sometimes they might be a sign or symptom of something greater like a.
Pituitary pathology or an endocrine disorder, or testosterone deficiency.
So we have to rule out some of the scary things, to get down to it.
And so we're really trying to listen to what the patient's are
saying when they're coming to us.
Melanie (Host): And then how is diagnosis made?
Kevin Campbell, MD: So diagnosis is made with signs and
symptoms of low testosterone.
A lot of those symptoms we talk about like fatigue, decreased energy,
decreased muscle mass, poor bone health, sometimes easy fractures.
so Those are the, subjective, aspects.
And then they have to have a low.
Morning testosterone value.
So testosterone, it's highest in the morning.
It peaks with a pulse eye release of GNRH in your pituitary, and
hypothalamus to then make LH and FSH and your LH goes to your testicles
and tells 'em to make testosterone.
And so that's signals highest in the morning And then starts
to decrease throughout the day.
So we do try to get a morning testosterone before 10:00 AM and depending on what
reference range or what lab value you're using, you're gonna have some.
Degree of, variation with that set number.
So in many labs, and FDA will say that's around 300 nanograms per deciliter.
And a testosterone below that, along with the signs and symptoms would,
give you reason to say somebody has testosterone deficiency.
Now if you look at, the Endocrine Society guidelines, they actually
take their testosterone number and use it as a statistical.
Reference and take two standard deviations beyond what's normal.
And so their reference range is gonna be around like two 50 to to nine 50 or so.
So you do see some change in the reference.
And then even with the, the Androgen Society And the Society of the
Aging male have used cutoffs as high as, three 50 in the past.
And so a lot of This is really geared at signs and symptoms
because not everybody has the same.
Need for a certain level of testosterone.
Not everyone has the same androgen receptors, so we have to look at the
objective And the subjective together.
Melanie (Host): Well, thank you for that.
So, Dr.
Campbell, as we look at a quick overview of the history of a UA
guidelines on male infertility, speak a little bit about the priority topics
addressed in the guidelines as they are today, and those statements.
Kevin Campbell, MD: This is a really timely question.
I'm glad you brought this up.
The first guidelines came out in 2020, and prior to that we had a
bunch of consensus statements and a lot of variations of different
particular aspects of male infertility.
But we didn't have any overarching or just, larger guidelines.
That men could look at.
And then those were updated in 2024 to continue to stay relevant with
a, just a couple of major changes.
But really the guidelines start And the work of starts with an evaluation,
a history physical of both partners, both the male And the female partner.
Because oftentimes, if we look at the breakdowns of what causes fertility,
there's a 30% male factor alone, 20% combined factor, and a 50% female factor.
So if you do some back of the envelope calculations and fudge the factors a
little bit, you can say that the male aspect contributes to at least 50% of
the infertility aspects for couples.
And 15% of couples will have degree of infertility.
And it might be something as, routine as a.
Different type of lifestyle modification that a patient may employ that we find
on the initial history and physical.
There might be a medication that someone's taking, or it might be in the history that
someone had some sort of chemotherapeutic or radiation that then may limit to what
degree we can restore sperm production or lend us to recommend surgery over
different stimulatory techniques.
So the first and biggest part of the workup is going to be the history.
And discussing with the patient And also finding their goals.
We have some couples who come in who are very young and they're just
starting to try their fertility journey and try to conceive, And so
there's a little bit more leeway.
We have some financial constraints as well sometimes, so we have
to take that all into account.
We.
Whereas if we have a couple that might be a decade or two older than that,
we're discussing potentially assisted reproductive therapies or ways to
optimize the fertility outcomes when we don't have the same sort of flexibility
that we may have with another couple.
So a lot of the basic workup for fertility a.
Goes into what I call the big three, and that's gonna be the
history and physical blood work.
So we can see how the hypothalamus And the testicles are talking
to each other And the pituitary and and how they all feed back.
And then also a semen analysis.
And when we get those big three, we can make a recommendation
of how to optimize fertility.
No one test can really say someone is fertile or infertile, but we
take all these things together to come up with our recommendations.
Melanie (Host): That was very comprehensive.
So first-line management of testosterone disorders.
Tell us a little bit about some of the therapies that are available right now.
Kevin Campbell, MD: Certainly, I think a lot of what goes into first-line
therapy when people are thinking about testosterone deficiency is going
to be giving somebody testosterone, and That is often the case.
However, one of the first steps that we have to evaluate is why
someone has low testosterone.
Is it a issue with the testicles?
Is it a issue with the pituitary?
Is it an issue with the hypothalamus?
Is it a, systematic or global insult to a patient's physiology?
are they on some, chemotherapeutic or some medication that causes
them to have blunting of this, HPG access or decreased testosterone?
there's bounces down, even after starting some medications that men often will use.
So it's important that we do, again, this history and physical and do this
workup, the mainstay of treatment.
It is often going to be replacement of testosterone or stimulatory therapy
if someone's trying to conceive.
We don't want to give that person testosterone right off the bat
because that can shut down their natural production of intra testicular
testosterone as well as sperm production.
So.
Many men who go on testosterone who are trying to conceive will
drop their sperm counts to zero.
Now we know that testosterone is not a contraceptive And that
people will get pregnant on testosterone, but it doesn't optimize
someone's ability to get pregnant.
So we have to take that into account.
And there are different, there's different therapies to, depending on
what hormones, are elevated or normal.
That we can employ.
So if someone's F, s, H and LH are say in the normal range, we might
try and stimulate that with say, a ER like Clomophine or in Clomophine
or Tamoxifen, or even give someone FSH or HCG, which is an analog of lh.
To try and stimulate testosterone production in the testicles.
Now, if that's not an issue or we're looking at an androgen deficiency or
a testosterone deficiency for, the aging male, we are gonna have a, more
robust discussion about the different types of formulations of testosterone.
There's almost a million formulations of testosterone out there, And that
That is been a little bit facetious, but there are quite a few, many of
which are all different types of, conjugated esters of testosterone.
Different lengths which may last a little bit longer in the body.
we will oftentimes use a injection either intramuscular, subcutaneous
that may last for a week or, two weeks or, or even 48 hours in some
of the shorter acting testosterones.
And then there's gels or creams that men will put either on their, upper
outer chest over the subclavians to absorb or the inner thigh or
even on the forearms, to absorb.
And that would be on a daily application.
So a lot of what goes into our first-line therapy is tailoring it to the patient.
I think it would be, inappropriate for us to give a, overall recommendation
of what works for everybody.
Because if we have the.
Gardner who's going outside every morning and is going to be sweating and has
to be up at, say, you know, 6:00 AM or when the sun's coming up, they're gonna
sweat off a lot of this testosterone gel where we might have somebody who is,
who has a fear of needles And so they don't, appreciate the idea of giving
themselves injection or maybe a tremor.
and once we've established a response to testosterone, we might move on
to pellets or even an intranasal gel or many other, applications as well.
So that's generally how we approach the first-line for testosterone management.
Melanie (Host): Well, thank you for that Dr.
Campbell.
So speak a little bit with all of these available therapies and more
tools in your toolbox all the time.
What factors should.
Other providers consider before recommending some of these therapies,
speak a little bit about any side effects, complications you
discuss with the patient's patient preference and lifestyle preference.
Speak about to other providers about what they should consider when they're looking
at all of these different therapies.
Kevin Campbell, MD: Yeah.
Thanks for bringing this up, Melanie.
This is very important because I think.
One testosterone application for one person is not the same for the next.
And so when someone comes to see me, we're gonna talk about the risk
and benefits of testosterone And then the modalities of treatment.
So let's talk about the risks and benefits first.
So.
There's definitive evidence to say that testosterone, if it's low And we
replace that, that can help with libido.
It can help with sex drive, it can help with increasing muscle mass and
decreasing visceral adipose tissue.
It can help with bone density and prevent osteoporosis, and it can
help with insulin sensitivity.
There Sporadic reports of it, helping also with mental cognition and brain fog.
Those are a little bit less reported in large studies and
having definitive evidence.
But we do have a lot of anecdotal evidence there and there are also risks involved.
Testosterone is a molecule that's seen by the body, so it's, we
call bioidentical, so it's not.
As high-risk as other synthetic molecules, but it does have an
effect on a body's physiology.
It can go to your bone marrow and tell it to make more red blood cells.
So if someone is undergoing testosterone therapy and not undergoing monitoring,
they can get polycythemia, they can have increased hematocrit,
they can put themselves at-risk for blood clots, for their legs, for
their hearts, and brains as well.
So there's a Non insignificant risk for heart attack, stroke, DBTs.
if someone has, polycythemia that's unchecked.
Now, testosterone has been proven to cause these, but secondarily, if
it's raising the hematocrit And that goes unchecked, it can lead to it.
So that's very important as a risk.
Another risk that.
It's very popular as prostate health.
So there is a misconception that testosterone causes prostate cancer.
Testosterone has never been known to cause prostate cancer since it's
been first synthesized in 1935.
So what we worry about though is that if someone has prostate cancer
and it goes to other parts of the body metastasizes, well then one of
the ways we know we can actually.
stop that spread or help kill the cancer is to starve it of testosterone.
So we do think of testosterone, in that regards as being a.
Lack of testosterone is a treatment for some prostate cancers and it can
So, it can help grow prostate cells.
So if someone's hypogonadal, they have low testosterone and they have potentially
a smaller prostate or a prostate that's not fully saturated by their androgens
'cause their testosterone's low.
And now you give someone testosterone, that prostate can respond in a
more robust way than it has been.
And so some people will see urinary tract symptoms like, like an increased
prostate size that can cause, what we call lutz, or increased urinary F frequency
hesitancy and growth of the prostate.
And with that comes an elevation of PSA, because if you have more
prostate tissue, you make more PSA.
Now it does not, again cause prostate cancer, but it is something we screen
for in this population because we're already seeing them And we wanna make sure
that if we're growing the prostate, if there's any already present, significant
prostate cancer, that we can catch it early and treat it appropriately.
Some of the other effects that we see or side effects with testosterone therapy
is how your body recycles testosterone.
There's enzymes in your, your natural adipose tissue and fat,
and your liver and brain, called aromatase, which will take your
testosterone and turn it into estrogen.
And so if that estrogen gets very high, that can also put
you at-risk for blood clots.
And it can decrease sex drive, it can decrease, erectile quality.
And so we have to take that into account and, monitor estrogen and
even put someone on an estrogen blocker if it gets too high.
But we also don't want to go too low because then that can put
someone at-risk for osteoporosis.
Some other issues we see with testosterone management are increased acne because
there's increased oil production by the skin think of someone when they're
going through puberty and, and they're getting these testosterone surges.
The, the skin produces more oil and sebum And that can cause
blockages of all the hair follicles.
Then, it's other times we can even see some hair thinning.
So if someone is prone to male pattern baldness.
Testosterone if, given in a, higher state, it can lead
to advanced in hair loss.
So all these are things we're taking into effect.
Now, when someone goes on testosterone, they may have a job that may not
allow them to have a daily application.
Like, let's say someone's traveling a lot and it's harder to travel with
hypodermic syringes or needles, then we may say, okay, a, daily application with
a gel or a cream will be best for you.
Versus if someone has a, maybe a deployment job or maybe a, job
that would say, let's go ahead and use a weekly syringe or even a
biweekly injection of testosterone, then certainly they can use that.
some providers, will also favor putting in pellets, for patient's.
And these last for about three months before they dissolve.
And so some patient's like the kind of the set it and forget it.
So all these are things that we, consider Some of the newer testosterones are
the oral formulations And the 1980s oral formulations were, were very
popular too, but they were alkylated.
And so every time somebody would take testosterone, it was putting a
little bit of pressure on the liver.
And so we.
Quickly, moved and pivoted from that application.
But now there are newer formulations.
There's three of 'em that are out now.
These types of testosterone, ECNO eight that get absorbed
with the lymphatics in the gut.
So you take them, once or twice a day and it brings your testosterone up.
So if someone doesn't wanna do a gel or a cream or an injection,
we have different options now.
So the future is bright for testosterone management.
Melanie (Host): Wow.
It's such an exciting time in your field, Dr.
Campbell, and you are such a wealth of knowledge.
As we wrap up, I'd like you to speak a little bit about lifestyle factors,
relationships between infertility and general health, and how you, as you
summarize, with shared decision-making.
Form your patient's of all of these different therapies And what goes
into the treatment options available.
Kevin Campbell, MD: Yes, This is really important because when
someone's coming in to be evaluated for either testosterone deficiency
or fertility, it's not always the.
Spend all, be all of that particular person.
This is oftentimes the peak of an iceberg where there's something underlying that
we really need to evaluate and treat.
We know that men who have increased fertility issues have an
increased morbidity and mortality.
There's a increase by one to 3%, higher mortality rate in
the infertility population.
And that might be because there's some overlying condition that we identify.
Sometimes There's no overlying condition that's identifiable.
But we do know that.
And treatment does have a burden as well.
So we have to keep all those things in mind.
When, evaluating for patient's for fertility.
Now sometimes people will come in and they understand their fertility
burden, but don't necessarily want treatment and just want answers.
And so really the workup is going to be dependent on the back and
forth with patient and provider.
So.
I would really harp on, this patient and physician model where we really
try to hear what the patient's saying and, and meet them where they're at.
Because if we're telling somebody that has low libido and decreased erectile quality
and decreased adipose, or increased adipose tissue, decreased muscle mass
that they need to go on testosterone.
But then they say, Hey, but I'm trying to also start a family, or I
wanna get pregnant in a couple years.
Well, now we've just added a degree of complexity that we can't overlook.
So we have to keep all these things in mind when going
forward with our patient care.
I.
Melanie (Host): Great information.
Dr.
Campbell.
Thank you again for joining us and sharing your incredible expertise
with other providers today.
And to learn more, you can visit uf health.org/specialties/urology,
or to learn more about this and other healthcare topics at UF Health
Shands Hospital, you can always visit innovation dot uf health.org.
That concludes today's episode of UF Health Med EdCast
with UF Health Han Hospital.
I'm Melanie Cole.